Publication | Closed Access

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

HepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyChronic Viral InfectionAntiviral DrugMedicineChronic InfectionTreatment-naive Patients